Huaren Pharmaceutical Co Ltd (300110) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.061x

Based on the latest financial reports, Huaren Pharmaceutical Co Ltd (300110) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥86.78 Million ≈ $12.70 Million USD) by net assets (CN¥1.43 Billion ≈ $208.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Huaren Pharmaceutical Co Ltd (300110) market capitalisation for the company's overall valuation and market capitalisation.

Huaren Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Huaren Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Huaren Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Huaren Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Huaren Pharmaceutical Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Synmosa Biopharma
TWO:4114
0.018x
Jaguar Mining Inc
TO:JAG
0.061x
Malam Team
TA:MLTM
-0.062x
Nanjing Zhongbei Group Co Ltd
SHE:000421
0.037x
Invesco California Value Muni Inc Tr
NYSE:VCV
0.018x
Tianjin Jieqiang Power Equipment Co
SHE:300875
-0.007x
KT Submarine Co. Ltd
KQ:060370
0.022x
Apex Healthcare Bhd
KLSE:7090
0.038x

Annual Cash Flow Conversion Efficiency for Huaren Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Huaren Pharmaceutical Co Ltd from 2007 to 2025. View Huaren Pharmaceutical Co Ltd (300110) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥909.06 Million
≈ $133.02 Million
CN¥390.23 Million
≈ $57.10 Million
0.429x +82.96%
2024-12-31 CN¥1.37 Billion
≈ $201.05 Million
CN¥322.36 Million
≈ $47.17 Million
0.235x +112.36%
2023-12-31 CN¥2.77 Billion
≈ $404.75 Million
CN¥305.60 Million
≈ $44.72 Million
0.110x +31.77%
2022-12-31 CN¥2.60 Billion
≈ $380.43 Million
CN¥217.98 Million
≈ $31.90 Million
0.084x +135.41%
2021-12-31 CN¥2.44 Billion
≈ $357.55 Million
CN¥-578.52 Million
≈ $-84.66 Million
-0.237x -5034.78%
2020-12-31 CN¥2.33 Billion
≈ $340.88 Million
CN¥-10.74 Million
≈ $-1.57 Million
-0.005x -103.35%
2019-12-31 CN¥2.25 Billion
≈ $329.02 Million
CN¥309.33 Million
≈ $45.26 Million
0.138x +21.89%
2018-12-31 CN¥2.25 Billion
≈ $329.72 Million
CN¥254.32 Million
≈ $37.21 Million
0.113x -17.22%
2017-12-31 CN¥1.55 Billion
≈ $226.55 Million
CN¥211.08 Million
≈ $30.89 Million
0.136x +14.53%
2016-12-31 CN¥1.53 Billion
≈ $223.29 Million
CN¥181.65 Million
≈ $26.58 Million
0.119x +813.41%
2015-12-31 CN¥1.44 Billion
≈ $210.71 Million
CN¥18.77 Million
≈ $2.75 Million
0.013x -70.59%
2014-12-31 CN¥1.48 Billion
≈ $216.53 Million
CN¥65.56 Million
≈ $9.59 Million
0.044x +62.55%
2013-12-31 CN¥1.46 Billion
≈ $213.55 Million
CN¥39.78 Million
≈ $5.82 Million
0.027x -63.29%
2012-12-31 CN¥1.34 Billion
≈ $195.97 Million
CN¥99.44 Million
≈ $14.55 Million
0.074x +48.64%
2011-12-31 CN¥1.19 Billion
≈ $174.38 Million
CN¥59.53 Million
≈ $8.71 Million
0.050x -28.93%
2010-12-31 CN¥1.10 Billion
≈ $161.57 Million
CN¥77.61 Million
≈ $11.36 Million
0.070x -42.90%
2009-12-31 CN¥313.80 Million
≈ $45.92 Million
CN¥38.63 Million
≈ $5.65 Million
0.123x -52.47%
2008-12-31 CN¥221.03 Million
≈ $32.34 Million
CN¥57.24 Million
≈ $8.38 Million
0.259x +524.40%
2007-12-31 CN¥184.68 Million
≈ $27.02 Million
CN¥7.66 Million
≈ $1.12 Million
0.041x --

About Huaren Pharmaceutical Co Ltd

SHE:300110 China Drug Manufacturers - Specialty & Generic
Market Cap
$474.01 Million
CN¥3.24 Billion CNY
Market Cap Rank
#12641 Global
#3711 in China
Share Price
CN¥2.74
Change (1 day)
+0.37%
52-Week Range
CN¥2.47 - CN¥3.62
All Time High
CN¥13.46
About

Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. The company also provides therape… Read more